Although the study is ongoing and the results not yet analyzed, a grin flashes across the face of a doctor leading the trial, Col. Foday Sahr, as he says that 80 percent of the recipients have lived.yessssss. very nice.
The countries really liked the blood option more than the drugs because there is no manufacturer behind it and no international regulatory approvals required.
Wednesday, February 18, 2015
Some Good News for a Change
Blood transfusions show early promise as possible Ebola cure